Literature DB >> 9721211

TGFbeta-inducible early gene (TIEG) also codes for early growth response alpha (EGRalpha): evidence of multiple transcripts from alternate promoters.

M P Fautsch1, A Vrabel, M Subramaniam, T E Hefferen, T C Spelsberg, E D Wieben.   

Abstract

TGFbeta-inducible early gene (TIEG) and early growth response alpha (EGRalpha) are putative transcription factors based on homology to known zinc finger proteins SP1, EGR1, BTEB, and Wilm tumor. Here we report that TIEG and EGRalpha are expressed from alternative promoters of the same gene. The TIEG/EGRalpha gene spans 8 kb and contains five exons. Use of alternative first exons results in TIEG having 12 unique amino acids on its N-terminus. Computer analysis of the 5' upstream regions of either TIEG (exon 1a) or EGRalpha (exon 1b) does not identify a TATA box or initiator sequencebut shows consensus sequence similarities to binding sites for several transcription factors including SP1,JunB, and aromatic hydrocarbon/receptor-ligand complexes. Analysis of constructs containing 5'-flanking regions show that both the TIEG and the EGRalpha promoters have significant activity in human fetal osteoblast cells. Northern analysis of mRNA from various human tissues and several cell lines reveals that TIEG is the predominant transcript produced and regulated by growth factors from the TIEG/EGRalpha gene. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9721211     DOI: 10.1006/geno.1998.5388

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

Review 1.  A tale of three fingers: the family of mammalian Sp/XKLF transcription factors.

Authors:  S Philipsen; G Suske
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

2.  Regulation of the juvenile hormone esterase gene by a composite core promoter.

Authors:  G Jones; Y X Chu; D Schelling; D Jones
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

Review 3.  Estrogen-TGFbeta cross-talk in bone and other cell types: role of TIEG, Runx2, and other transcription factors.

Authors:  J R Hawse; M Subramaniam; J N Ingle; M J Oursler; N M Rajamannan; T C Spelsberg
Journal:  J Cell Biochem       Date:  2008-02-01       Impact factor: 4.429

4.  TGFbeta inducible early gene-1 (TIEG1) and cardiac hypertrophy: Discovery and characterization of a novel signaling pathway.

Authors:  Nalini M Rajamannan; Malayannan Subramaniam; Theodore P Abraham; Vlad C Vasile; Michael J Ackerman; David G Monroe; Teng-Leong Chew; Thomas C Spelsberg
Journal:  J Cell Biochem       Date:  2007-02-01       Impact factor: 4.429

5.  Identification of an enhancer and an alternative promoter in the first intron of the alpha-fetoprotein gene.

Authors:  S Scohy; P Gabant; C Szpirer; J Szpirer
Journal:  Nucleic Acids Res       Date:  2000-10-01       Impact factor: 16.971

6.  Functional interplay between E2F1 and chemotherapeutic drugs defines immediate E2F1 target genes crucial for cancer cell death.

Authors:  David Engelmann; Susanne Knoll; Daniel Ewerth; Marc Steder; Anja Stoll; Brigitte M Pützer
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

Review 7.  Functional role of KLF10 in multiple disease processes.

Authors:  Malayannan Subramaniam; John R Hawse; Nalini M Rajamannan; James N Ingle; Thomas C Spelsberg
Journal:  Biofactors       Date:  2010 Jan-Feb       Impact factor: 6.113

8.  Erythroid Krüppel-like factor directly activates the basic Krüppel-like factor gene in erythroid cells.

Authors:  Alister P W Funnell; Christopher A Maloney; Lucinda J Thompson; Janelle Keys; Michael Tallack; Andrew C Perkins; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2007-02-05       Impact factor: 4.272

9.  The basal transcriptional activity of the murine Klf10 gene is regulated by the transcriptional factor JunB.

Authors:  Azra Memon; Yuliya Pyao; Yerin Jung; Hwa-Sik Choi; Ki-Duk Song; Woon Kyu Lee
Journal:  Genes Genomics       Date:  2021-02-08       Impact factor: 1.839

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.